This site demonstrates one possible use of this domain. For acquisition, partnership, or investment inquiries, please use our contact link.
Ketalux - Ketamine Therapy Education
Glossary

REMS

FDA risk evaluation and mitigation strategy program.

Medically reviewed by: Pending medical review(draft)Last updated: June 4, 2026Evidence: Educational definition

REMS programs apply additional monitoring requirements to certain drugs. Esketamine (Spravato) is dispensed only under a REMS program requiring in-clinic administration and observation.

Related terms

Definitions are educational and general. They are not medical advice.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.